Anthony Scalzo

The use of neuroendocrine immunoperoxidase markers to predict chemotherapy response in patients with non-small-cell lung cancer

Journal of Clinical Oncology · 1989 · Last of 9 authors · 168 citations

Cisplatin, vinblastine, and hydrazine sulfate in advanced, non-small-cell lung cancer: a randomized placebo-controlled, double-blind phase III study of the Cancer and Leukemia…

Journal of Clinical Oncology · 1994 · 77 citations